These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37831167)

  • 1. Interobserver agreement and prognostic value of image-based scoring systems in patients with primary sclerosing cholangitis.
    Grave EC; Loehfelm T; Corwin MT; Zepeda J; Bath HK; Dhaliwal S; Yazdanfar M; Bowlus CL
    Abdom Radiol (NY); 2024 Jan; 49(1):60-68. PubMed ID: 37831167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis.
    Lemoinne S; Cazzagon N; El Mouhadi S; Trivedi PJ; Dohan A; Kemgang A; Ben Belkacem K; Housset C; Chretien Y; Corpechot C; Hirschfield G; Floreani A; Motta R; Gallix B; Barkun A; Barkun J; Chazouillères O; Arrivé L
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2785-2792.e3. PubMed ID: 30880273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of prognostic value and interreader agreement of ANALI scores in patients with primary sclerosing cholangitis.
    Grigoriadis A; Ringe KI; Andersson M; Kartalis N; Bergquist A
    Eur J Radiol; 2021 Sep; 142():109884. PubMed ID: 34380098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture.
    Poetter-Lang S; Ba-Ssalamah A; Messner A; Bastati N; Ambros R; Kristic A; Kittinger J; Pochepnia S; Ba-Ssalamah SA; Hodge JC; Halilbasic E; Venkatesh SK; Kartalis N; Ringe K; Arrivé L; Trauner M
    Eur Radiol; 2024 Jun; ():. PubMed ID: 38869640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Cazzagon N; Lemoinne S; El Mouhadi S; Trivedi PJ; Gaouar F; Kemgang A; Ben Belkacem K; Floreani A; Hirschfield G; Chretien Y; Housset C; Motta R; Russo FP; Chazouillères O; Arrivé L; Corpechot C
    Am J Gastroenterol; 2019 Dec; 114(12):1878-1885. PubMed ID: 31738286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of quantitative MRCP (MRCP+) for risk stratification of primary sclerosing cholangitis: comparison with morphological MRCP, MR elastography, and biochemical risk scores.
    Ismail MF; Hirschfield GM; Hansen B; Tafur M; Elbanna KY; Goldfinger MH; Ridgway GR; Jhaveri KS
    Eur Radiol; 2022 Jan; 32(1):67-77. PubMed ID: 34231037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of magnetic resonance imaging of the abdomen with intravenous contrast and magnetic resonance cholangiopancreatography in primary sclerosing cholangitis.
    Grove RL; Vespa F; Aineseder M; Villamil A; Spina JC
    Radiol Bras; 2023; 56(6):301-307. PubMed ID: 38504819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis.
    Cazzagon N; El Mouhadi S; Vanderbecq Q; Ferreira C; Finnegan S; Lemoinne S; Corpechot C; Chazouillères O; Arrivé L
    JHEP Rep; 2022 Nov; 4(11):100577. PubMed ID: 36277957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Quantitative Magnetic Resonance Cholangiopancreatography Metric of Intrahepatic Biliary Dilatation Severity Detects High-Risk Primary Sclerosing Cholangitis.
    Selvaraj EA; Ba-Ssalamah A; Poetter-Lang S; Ridgway GR; Brady JM; Collier J; Culver EL; Bailey A; Pavlides M
    Hepatol Commun; 2022 Apr; 6(4):795-808. PubMed ID: 34802195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis.
    Grigoriadis A; Imeen Ringe K; Bengtsson J; Baubeta E; Forsman C; Korsavidou-Hult N; Rorsman F; Nilsson E; Kartalis N; Bergquist A
    JHEP Rep; 2022 Dec; 4(12):100595. PubMed ID: 36444388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis.
    Cristoferi L; Porta M; Bernasconi DP; Leonardi F; Gerussi A; Mulinacci G; Palermo A; Gallo C; Scaravaglio M; Stucchi E; Maino C; Ippolito D; D'Amato D; Ferreira C; Nardi A; Banerjee R; Valsecchi MG; Antolini L; Corso R; Sironi S; Fagiuoli S; Invernizzi P; Carbone M
    Dig Liver Dis; 2023 Mar; 55(3):373-380. PubMed ID: 36357293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of magnetic resonance imaging and endoscopic retrograde cholangiography in the evaluation of disease activity and severity in primary sclerosing cholangitis.
    Tenca A; Mustonen H; Lind K; Lantto E; Kolho KL; Boyd S; Arola J; Jokelainen K; Färkkilä M
    Liver Int; 2018 Dec; 38(12):2329-2339. PubMed ID: 29901259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of disease severity with magnetic resonance cholangiography in pediatric-onset primary sclerosing cholangitis.
    Vanhanen E; Ovissi A; Kolho KL; Tenca A
    J Pediatr Gastroenterol Nutr; 2024 Sep; 79(3):644-651. PubMed ID: 39014988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease.
    Song C; Lewis S; Kamath A; Hectors S; Putra J; Kihira S; Bane O; Ahmad J; Babb J; Thung S; Taouli B
    Abdom Radiol (NY); 2020 Feb; 45(2):354-364. PubMed ID: 31844914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
    de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
    Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Performance of Quantitative and Qualitative Magnetic Resonance Imaging Metrics in Primary Sclerosing Cholangitis.
    Eaton JE; Welle CL; Monahan H; Tahboub Amawi AD; Idilman I; Harmsen WS; Dzyubak B; Beiermann EW; Bakhshi Z; Gores GJ; LaRusso NF; Gossard AA; Lazaridis KN; Venkatesh SK
    Gastro Hep Adv; 2022; 1(3):287-295. PubMed ID: 39131684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of liver stiffness measurement with MRE and liver and spleen volumetry for prediction of disease severity and hepatic decompensation in patients with primary sclerosing cholangitis.
    Idilman IS; Low HM; Bakhshi Z; Eaton J; Venkatesh SK
    Abdom Radiol (NY); 2020 Mar; 45(3):701-709. PubMed ID: 31894383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
    Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
    Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis.
    Mazhar A; Russo MW
    Aliment Pharmacol Ther; 2021 Apr; 53(7):774-783. PubMed ID: 33608929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of imaging in determining prognosis for primary sclerosing cholangitis: A systematic review.
    Segal D; Marotta P; Mosli M; Zou G; Feagan BG; Al-Judaibi B
    Saudi J Gastroenterol; 2019; 25(3):152-158. PubMed ID: 31044745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.